about IPA

About IPA

The Indian Pharmaceutical Alliance (IPA) represents 24 leading research-based Indian pharmaceutical companies. IPA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Know more

Our Resources

  • Articles

    Manufacturing cooperation is key to equitable access of vaccines across countries: Dr. Rajesh Jain

    July 15, 2021

  • External Studies and Reports

    A Vision for the Global Generic and Biosimilar Medicines Industry Whitepaper

    July 7, 2021

  • Articles

    IGBA launches whitepaper on global generic and biosimilar medicines industry

    July 7, 2021

  • Position Papers

    IPA Submission – USTR Special 301 Report

    January 29, 2021

  • Position Papers

    IPA Employee Safety Initiatives Report

    January 25, 2021

  • External Studies and Reports

    Beyond Business – Contributions to Social Initiatives_IPA Samhita

    December 14, 2020

  • Presentations

    The Indian pharmaceutical industry and global market

    September 30, 2019

  • Presentations

    New International Healthcare Policies in Making Perspective from India – Warsaw

    June 13, 2019

Know more

Our Videos

  • July 7, 2021

    Whitepaper: a Vision for the Global Generic and Biosimilar Medicines Industry

    Click to Play
  • June 17, 2021

    IPA E-Knowledge series with Pharma leadership: Dr. Rajesh Jain

    Click to Play
  • April 7, 2021

    Mr. Sudarshan Jain shares his thoughts on ‘World Health Day’

    Click to Play
  • April 5, 2021

    IPA HR Leadership Series – Webinar on “Impact of Labour Codes on Rewards”

    Click to Play
  • March 18, 2021

    IPA Manufacturing and Quality Workshops: Webinar 6 – “Operational Excellence in Pharma”

    Click to Play
  • March 15, 2021

    6th IP Forum: CEO Panel Discussion: COVID-19 impact on Pharmaceutical Industry

    Click to Play
  • March 15, 2021

    6th IPF 2021: Panel discussion – Digitalisation/automation and artificial intelligence…

    Click to Play
  • March 15, 2021

    6th IP Forum: Day 3 – Session 12 on ‘Quality compliance culture & empowerment in the…

    Click to Play
  • March 15, 2021

    6th IP Forum: Day 3 – Session 11 by Dr. Ghada Haddad – Exec. Director, Merck & Co.

    Click to Play
  • March 15, 2021

    6th IP Forum: Day 3 – Session 11 by Mr. Richard Johnson

    Click to Play